Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brentuximab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07002216
What this trial is testing

BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaAdvanced Hodgkin Lymphoma
University of Miami 48
Testing effectiveness (Phase 2)UnknownNCT03527628
What this trial is testing

OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy

Who this might be right for
Classical Hodgkin LymphomaHodgkin Lymphoma (Category)Hodgkin Disease+1 more
King Abdullah International Medical Research Center 220
Testing effectiveness (Phase 2)Study completedNCT03264131
What this trial is testing

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Who this might be right for
LymphomaAdult T-Cell Leukemia/LymphomaLymphatic Diseases
UNC Lineberger Comprehensive Cancer Center 16
Large-scale testing (Phase 3)UnknownNCT06186986
What this trial is testing

CD30 Imaging in Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell-lymphoma
University Medical Center Groningen 20
Large-scale testing (Phase 3)Looking for participantsNCT06563245
What this trial is testing

Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment

Who this might be right for
Classical Hodgkin LymphomaChildAdolescent+6 more
Children's Cancer Group, China 96
Testing effectiveness (Phase 2)Looking for participantsNCT04587687
What this trial is testing

Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Recurrent Follicular LymphomaRefractory Follicular Lymphoma
University of California, Davis 23
Large-scale testing (Phase 3)Active Not RecruitingNCT02166463
What this trial is testing

Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage IIB Hodgkin LymphomaAnn Arbor Stage IIIB Hodgkin LymphomaAnn Arbor Stage IVA Hodgkin Lymphoma+3 more
National Cancer Institute (NCI) 600
Testing effectiveness (Phase 2)Study completedNCT01994850
What this trial is testing

Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients

Who this might be right for
CD30 Positive Primary Mediastinal Large B-cell LymphomaCD30-Positive Diffuse Large B-Cell LymphomaCD30-Positive Gray Zone Lymphoma
Abramson Cancer Center at Penn Medicine 32
Testing effectiveness (Phase 2)Study completedNCT01508312
What this trial is testing

Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT02423291
What this trial is testing

SGN-35 (Brentuximab Vedotin) of Patients With Relapsed or Refractory PMLBCL

Who this might be right for
Primary Mediastinal Large B Cell Lymphoma
Fondazione Italiana Linfomi - ETS 15
Testing effectiveness (Phase 2)Study completedNCT02388490
What this trial is testing

Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas

Who this might be right for
Relapsed or Refractory EBV-and CD30-positive Lymphomas
Seoul National University Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT05313243
What this trial is testing

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

Who this might be right for
T-Cell Lymphoma
Yale University 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT03517137
What this trial is testing

Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study

Who this might be right for
Advanced Hodgkin Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 150
Testing effectiveness (Phase 2)Ended earlyNCT02533570
What this trial is testing

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

Who this might be right for
Systemic Lupus Erythematosus
Seagen Inc. 20
Testing effectiveness (Phase 2)Study completedNCT03217643
What this trial is testing

CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1.

Who this might be right for
Enteropathy Associated T-cell Lymphoma
Imagine Institute 14
Testing effectiveness (Phase 2)Study completedNCT01716806
What this trial is testing

Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Hodgkin DiseasePeripheral T Cell Lymphoma
Seagen Inc. 131
Testing effectiveness (Phase 2)Active Not RecruitingNCT01352520
What this trial is testing

SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

Who this might be right for
CD-30 Positive Anaplastic Large T-cell Cutaneous LymphomaLymphoma, Primary Cutaneous Anaplastic Large CellLymphomatoid Papulosis+5 more
M.D. Anderson Cancer Center 79
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06919679
What this trial is testing

Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma (Category)
University of Cologne 35
Testing effectiveness (Phase 2)Study completedNCT03496779
What this trial is testing

Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With Gemcitabine

Who this might be right for
Refractory Peripheral T-Cell LymphomaRelapsed Peripheral T-Cell Lymphoma
The Lymphoma Academic Research Organisation 71
Testing effectiveness (Phase 2)Temporarily pausedNCT03187210
What this trial is testing

Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas

Who this might be right for
Lymphoma
Insel Gruppe AG, University Hospital Bern 20
Next Page